FDA & Life Sciences partner Chris Markus and senior quality systems expert Anne Kelly will be featured speakers at the Food and Drug Law Institute’s Introduction to U.S. Biologics and Biosimilars Law and Regulation conference on March 15-16. The conference will explore regulatory requirements applicable to biological products, including biotechnology-derived therapeutic proteins, human tissue, gene and cell products. Chris will focus on the biologics license application process and marketing authorizations. Anne will address the regulation of biological manufacturing and current good manufacturing practices. More information can be found here.